1-1 of 1
Lena Macukanovic-Golubovic
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Randomized Phase 2 Trial of Bortezomib–Dexamethasone Versus Bortezomib–Dexamethasone with Added Cyclophosphamide or Lenalidomide in Multiple Myeloma Patients Achieving Stable Disease After Four Cycles of Bortezomib–Dexamethasone Administered as Second-Line Treatment.

Meletios A. Dimopoulos, Huw Roddie, Meral Beksac, Lotfi Benboubker, Romualdas Jurgutis, Christian Langer, Javier de la Rubia, Luis Felipe Casado, Kazimierz Kuliczkowski, Lena Macukanovic-Golubovic, Thierry Facon
Journal: Blood
Blood (2009) 114 (22): 4937.
https://doi.org/10.1182/blood.V114.22.4937.4937
Published: 2009